Background: A critical issue for multicentre clinical studies is conducting site
INTRODUCTION
Properly conducted clinical studies are essential for the application of evidence based healthcare (1) . Multicentre studies, where more than one independent centre collaborates in the tasks of enrolling and following study participants (2) , are important to increase both recruitment rates and the external validity of findings.
A particular challenge in the conduct of multicentre studies is ensuring that sites are appropriately trained in study procedures and comply with relevant governance requirements (3) . To address this challenge, all sites that are participating in a study are required to undergo an initiation process before they can begin recruiting patients to the study (4) . Site initiations typically cover everything from governance requirements, study specific requirements such as patient eligibility, study specific procedures, and randomisation etc. through to data management issues such as how to complete and return the case report forms (CRFs), and adverse event reporting. Effective processes for communicating this information are essential for the success of the study; failure in adequately communicating these points could result in data being collected on ineligible patients, failing to comply with legislation, inconsistent application of the intervention, and missing data, all of which not only represent a waste of resources but could threaten patient safety and the validity of the study (5) . Delays in this process reduce the time subsequently available within the study for recruitment of patients. Additionally, site updates may be required if there is an amendment to the study protocol. Timeliness of the delivery of such updates is of particular importance when protocol amendments are made due to safety concerns that have arisen. Site initiations and updates are typically delivered through on-site visits but these can be costly in terms of time and travel expenses, particularly in studies covering wide geographical areas, with a subsequent environmental impact (6) . Teleconferences have been used as an alternative method of delivery but the absence of face-to-face contact may have a negative impact on communication.
One of the objectives of clinical research informatics (CRI) is 'to optimise the design and conduct of clinical research' (7). While attention within CRI has been given to recruitment of patients to clinical studies (8) and electronic collection, storage, and management of study data (9) (10) (11) (12) (13) , how technology can support the site initiation process in multicentre studies has not been explored, despite this being a critical issue in relation to recruitment of patients and subsequent success of the study. As part of the CODIFI study, which assessed concordance between different wound sampling techniques in patients with infected diabetic foot ulcers, we delivered site initiations and updates through web based videoconferencing (14) . We considered this would allow us to cut time and travel costs in comparison to on-site visits while providing face-to-face communication that would facilitate more effective two-way communication in comparison to teleconferencing. To evaluate the use of web based videoconferencing for this purpose, we invited participants in the site initiations and updates to complete a questionnaire survey and participate in a follow up telephone interview. Our aim was to explore participants' experience of using the technology and its acceptability to participants as a method for receiving site initiations and updates. To our knowledge the use of videoconferencing to deliver site initiations is novel and has not previously been reported. Below we first consider existing studies of videoconferencing within the health informatics literature and more widely, before describing our study methods and presenting our results. We conclude the paper by discussing the implications of our findings for future research and for those wishing to use videoconferencing in support of site initiations and updates.
Videoconferencing in healthcare
Videoconferencing is not a new technology (15, 16) and has been in use in healthcare for more than 15 years (17) . However, to our knowledge, only one study has previously explored the use of videoconferencing to facilitate the conduct of multicentre studies (3) . Videoconferencing, in combination with telephone, email, and in-person visits, was used to support: standardisation of study processes, with the trial coordinator using videoconferencing to assess patients; patient management; clinical follow-up and monitoring of patients; and writing up the results for publication.
However, site initiations were conducted in person, because the study authors considered that initial personal contact between the participants was necessary to develop rapport before introducing videoconferencing. While regular updates were provided by email, occasionally videoconferencing and telephone were used when immediate feedback on updates was required.
Other studies of videoconferencing within health informatics cover a broad spectrum of clinical applications, being concerned with communication between healthcare professionals and patients (18, 19) , communication between two or more healthcare professionals (20) (21) (22) (23) (24) (25) , and communication for the purpose of education and training of healthcare professionals (17, 26, 27) . Demeris et al. (18) describe the use of videoconferencing for remote dermatology consultations. Comparing face-to-face and remote dermatology consultations, they found patterns of communication were similar, with no apparent negative consequences for the quality of communication.
There was no significant difference in the duration of consultations in the two conditions, although there was a significant difference in the percentage of consultations in which general informal talk was observed, being more frequently observed in the remote consultations. Kane and Luz (22) For example, this has included multiple cameras configured for the particular locations, shared access to multiple sources of data such as x-rays, and sometimes additional technology, e.g. a pen and tablet display system (19) . The creation and use of such 'blended interaction spaces' (28) is motivated in part by early studies from other fields that point to the challenges of video-mediated communication.
While use of videoconferencing, as opposed to teleconferencing, is based on the assumption that there is value for participants in a meeting to be able to see as well as hear each other, a study comparing videoconferencing with co-located conversations and audio-only conversations found that videoconferencing conferred no benefits over the audio-only condition, although participants perceived the visual access provided by videoconferencing to be important and beneficial (16) . Heath and Luff (15) describe the ineffectiveness of gesture and other forms of body movement such as gaze when communicating through video, with the consequence that speakers may delay or even abandon an utterance due to failing to obtain the relevant response from a recipient. Other studies suggest that while videoconferencing can provide benefits in terms of efficiency, the impressions that people form of remote others are less positive than impressions that are formed in face-to-face meetings (29) . 
METHODS
CODIFI recruited 400 patients from 26 sites across England. It assessed concordance between microbiological results obtained from a wound swab and a small piece of tissue removed from the same area of the wound bed. A protocol amendment was released after the study had opened to recruitment, following additional funding, which enabled sites to complete a 12 month casenote review and some sites to collect a second swab for Polymerase Chain Reaction analysis through a commercial partner.
Adobe Connect (Adobe Systems, San Jose, California, USA), a web based videoconferencing platform that allows simultaneous delivery of PowerPoint presentations, was used for providing remote site initiations and updates. For the site initiations, the study team decided to do face-to-face initiations to local sites while they became familiar with the Adobe Connect technology. Consequently, videoconferencing was used for site initiations for 11 of the 26 sites, and then updates to all 26 sites (see Figure I for a summary of study steps with number of sites/participants). Prior to the initiations and updates via videoconferencing, sites were sent detailed step by step instructions for logging into Adobe Connect. Test presentations were arranged to ensure local firewalls permitted access to Adobe Connect and to ease any concerns about the technology. As this was a pragmatic observational study, system configurations varied depending on the facilities available at different sites with no additional hardware provided through the study and with the study team having no control over the configurations used. Sites with a webcam and microphone were able to use these, therefore enabling full two-way videoconferencing. Where sites did not have access to a microphone, we used a telephone in conjunction with the videoconferencing, with sites communicating through a speaker phone. Sites were encouraged to project images onto a screen to enable adequate visualisation of the presentation slides but, more often, a standard desktop computer was used. One site participated using an iPad.
[ Figure I should go approximately here]
The site initiation covered the background to the study, guidelines for clinical trial processes, and key study management issues such as the processes for recruitment, consent, registration, CRF completion, and data transfer. Additionally, instructional videos of the techniques for collecting the different samples were streamed live during the presentation. In updates following the protocol amendment, how to package an additional sample for a commercial lab was demonstrated using the webcam.
Questionnaire survey
To evaluate the use of web based videoconferencing as a method for remotely delivering site initiation training and updates, we created an online questionnaire based on the System Usability Scale (SUS) questionnaire. We chose to use the SUS because it is a validated tool that is technology agnostic, meaning that it can be used to assess a wide range of technologies, and it is relatively quick and easy to complete (30) . The questionnaire was composed of 10 statements scored on a 5-point scale of strength of agreement (where 1 = strongly disagree and 5 = strongly agree) designed to capture respondents' perceptions of the usability of a technology.
The questionnaire asked respondents to record their gender and role and to rate their confidence in using a computer on a 7-point scale (where 1 = not confident at all and 7 = very confident). The questionnaire also provided a space for participants to record additional comments about their experience of using the videoconferencing tool.
During site initiations to three of the sites and updates to all 26 sites, we introduced the survey. This was followed by an email to all who participated in the initiation/update, with an invitation to participate and a link to the survey. Participation in the survey was anonymous, unless participants chose to provide their contact details in order to take part in the interview study.
The SUS data were analysed to provide an overall rating per participant using the standard methodology for the questionnaire (31) . SUS scores can range from 0 to 100, where higher scores indicate better usability. Scores of 70 or above are considered acceptable, with better products scoring in the high 70s or above (30) .
Thematic content analysis was used for analysis of the free text comments. Because the survey was anonymous, it was not possible to analyse the responses by site to allow for cross-site comparison.
Telephone interviews
Following the questionnaire survey, we contacted via email those respondents who had provided contact details and invited them to participate in a brief semi-structured telephone interview. Interview questions explored what participants saw as the benefits and limitations of videoconferencing for site initiations and updates in comparison to face-to-face and teleconference site initiations and updates. Probes were developed based on the free text comments received via the survey. All interviews were audio recorded and later transcribed.
An iterative approach was taken to data collection and analysis, to allow the collection of further data on emerging themes in subsequent interviews. Anonymised transcripts were entered into NVivo 10, software for qualitative data analysis. Data were analysed using thematic content analysis with codes developed inductively.
Matrix displays were used to identify patterns in the data (32).
RESULTS
Use of videoconferencing enabled initiations to be conducted at geographically distant sites on the same day. Use of this method expedited the set up phase of the study. Consequently, the study opened to recruitment two months ahead of schedule, enabling us to maximise the percentage of the study time in which recruitment could take place, and recruitment was ahead of target for the 14 months from November 2011 to December 2012. The technology also enabled faster roll out of the subsequent protocol amendment. While we did not conduct inferential statistical analysis, there were no obvious differences between sites that received a face-to-face site initiation and those that received a site initiation via videoconferencing in the adequacy of their data collection procedures or the completeness of the CRFs, leading the study team to conclude that use of videoconferencing had no negative impact on participants' understanding of the information that was communicated.
Below we present the results of the questionnaire survey before presenting the findings from the interviews, organised according to key themes.
Questionnaire survey
Fifteen responses to the survey were received and nine respondents provided free text comments. One podiatrist, two diabetologists, one trial co-ordinator, and 11 research nurses completed the survey. Eleven of the 15 respondents were female.
The mean rating for confidence in computer use was 6.6 (range 5-7). As responses to the survey were anonymous, unless respondents chose to provide their contact details, it is not possible to report how many sites participated in the survey.
However, nine respondents did provide their contact details and all were from different sites, indicating that a minimum of nine sites participated in the survey. One respondent suggested that rapport would be better with a face-to-face initiation.
Only one respondent commented on the benefits of being able to see the presenter:
'I found it useful as you can see the person on the other end and they can demonstrate, show study materials to us to familiarise with them.' (Research nurse 4)
One respondent questioned whether the system would be appropriate for more complex studies but suggested that videoconferencing could be used in combination with face-to-face site initiations.
Telephone interviews
Five participants, from five different sites, were recruited to take part in the interviews. The interview participants were three research nurses, one consultant diabetologist, and one trial coordinator. All interviewees had previous experience of participating in multicentre studies and had previously mainly experienced face-toface site initiations. Two of the interviewees (Research nurse 3 and Trial coordinator) had participated both in the site initiation and update by videoconferencing, while the other interviewees had received a face-to-face initiation and the update by videoconferencing. Four of the five interviewees participated using a standard National Health Service (NHS) owned desktop computer, only one of which had a webcam, and one interviewee participated using an iPad. Information about the system configuration experienced by each interviewee is provided in Table I. [ Table I should go approximately here]
Acceptability
Three interviewees were very positive about the experience of using videoconferencing:
'It was fantastic… I think it's a fantastic system.' (Consultant diabetologist)

'Everybody was sort of like, oh this really good, this has worked really well.' (Research nurse 1)
'It was very good.' (Trial coordinator)
One of the research nurses preferred face-to-face site initiations but saw videoconferencing as an 'acceptable alternative' and described finding the presentation 'very easy to follow', while another research nurse saw it as no better or worse than a face-to-face site initiation. All interviewees perceived videoconferencing as preferable to telephone only site initiations. Interviewees also commented on the benefits of being able to see the presenter so that the presenter could show them the practicalities of how to label and package samples.
Impact on communication
Despite some concern over the ability to build rapport, none of the interviewees felt that having the initiation via videoconferencing rather than face-to-face made a difference to the amount of questions that people asked. In comparison to telephone only initiations, one interviewee commented on the way in which the PowerPoint slides supported participants in asking questions: One interviewee also pointed to the benefit of the chat facility that is part of Adobe Connect, allowing people to ask questions as they thought of them, without having to talk over each other.
'It was nice to be able to chat through the slides as he went through and obviously
Impact on time
Saving time was one of the anticipated benefits for the study team but it was also perceived as a benefit for the participants. We estimate that on average the videoconferencing site initiations took approximately 60 minutes, while a face-to-face initiation would typically last 90 minutes. Two interviewees talked of the benefit of the update taking less time in comparison to face-to-face updates:
'It fits into our day so we're not having to block off whole, you know, afternoons or mornings and cancel stuff, it's just it was beautifully arranged so that it could be done between clinics or lunchtime or whatever.' (Consultant diabetologist)
One interviewee explained how, with a site visit, they feel that they have to make the most of the time that the presenter was there, whereas with the videoconferencing they felt that they could always just speak on the telephone if they wanted to clarify something: However, this issue was not raised by the other interviewees and, when prompted, two of them said that they felt there was no difference in the preparation time required.
Practical challenges
Interviewees were asked how many participants were present for the videoconferencing sessions at their site. Of the two interviewees who had their site initiation by videoconferencing, one reported that there were three participants in the initiation, while the other interviewee reported that there were two participants. The mean number of participants in the updates across the five sites was three (range [1] [2] [3] [4] [5] . One interviewee said that they would like a larger screen to better see the presenter, while another interviewee described how using a standard desktop computer meant that the screen was cluttered and everyone was 'huddled around': However, another interviewee did not mind everyone sitting around the computer, saying that they were used to working that way.
One interviewee had to get their IT department to provide access to Adobe Connect and was only allowed access for a limited time. However, the other four interviewees said that they experienced no technical difficulties and did not require any support from IT staff within their organisation. Our experience suggests that videoconferencing is a viable alternative to face-toface site initiations, at least for uncomplicated studies, even in settings without specific hardware such as webcams and large display screens, and offers benefits over teleconferencing. However, when sites do use a webcam, this may be beneficial, both in terms of building rapport and to enable participants to point to features of forms or equipment in order to seek clarification. Use of videoconferencing makes it feasible to deliver the site initiation over more than one session; the shorter duration of the site initiation when delivered by videoconference, in comparison to face-to-face initiations, may mean that study teams wish to do this, enabling staff at the local site to come back with further questions after the initial presentation. One of our sites used an iPad and the Adobe Connect app to participate in the sessions; the use of the FaceTime video calling service available with iPads and iPhones has been recommended for supporting more informal, spontaneous discussion between remote healthcare professionals (33) but may equally be beneficial for supporting more informal, spontaneous discussion between sites and the study team. More generally, study teams could consider incorporating videoconferencing as one element of building relationships with sites, for example conducting site initiations face-to-face but using videoconferencing for updates.
Limits of videoconferencing
Future trials could compare the impact of conducting site initiations via videoconferencing on site performance as a nested trial within a larger clinical study.
Limitations
This paper describes the use of web based videoconferencing for a fairly simple clinical study, so that the findings may not be generalisable to more complex multicentre clinical trials. The generalisability of our evaluation is also limited by the small number of participants in the evaluation. In particular, participants were selfselecting; all survey respondents reported a reasonably high level of confidence in computer use, so it may be that the evaluation captured those who had a more positive attitude towards the technology. Another limitation is that we were unable to undertake cross-site comparisons of the survey data due to the anonymous nature of the data collected. Finally, this evaluation describes participants' perceptions of the differences between site initiations that are delivered via videoconferencing, teleconferencing, or face-to-face and the study team's perceptions of the success of the initiations in effectively communicating the necessary information. However, previous research has shown that while participants may value videoconferencing, it confers no benefits for communication over teleconferencing (16); we did not attempt to measure differences in duration or the communication differences and the study was not adequately powered to identify statistical differences in the adequacy of data collection procedures (e.g. protocol breaches) or completeness of the CRFs.
CONCLUSIONS
To our knowledge this is the first report of the use of web based videoconferencing to deliver site initiations. Our experience suggests that videoconferencing is a viable alternative to face-to-face site initiations, at least for fairly simple studies, even in settings without specific hardware such as webcams and large display screens, and offers benefits over teleconferencing. We hope that future multicentre clinical studies will incorporate a formal evaluation of videoconferencing technologies on site performance, including gathering observational data on the differences in communication (including duration) and quantitative data on the impact of method of delivery on participants' understanding of the information communicated and consequences for data collection (e.g. number of protocol breaches and completeness of CRFs). Consideration should also be given to the economic and environmental benefits of reducing the time and travel requirements during set-up, and the subsequent impact on recruitment. 
